Abstract
Introduction
Adrenal incidentalomas (AIs) have been associated with an increased incidence of several cardiovascular risk factors. The aim of this study was to investigate plasma adiponectin, leptin, resistin, homocysteine, high sensitive C-reactive protein levels, and carotid intima media thickness (CIMT) in patients with non-functioning AI (NFAI).
Materials and methods
This study included data from 28 patients with NFAI (Group 1) and 41 controls (Group 2). Of the patients, 50 were female and 19 were male, and the mean age was 46.7 (range 37–65) years.
Results
There were no significant differences between Group 1 and 2 in terms of age, sex, or BMI. Hypertension prevalence was significantly higher in the NFAI group than in the control group (p = 0.01). Both groups had similar lipid, blood glucose, homocysteine, uric acid, high-sensitivity CRP levels. Adiponectin, leptin, and resistin levels were similar in both groups. CIMTs were significantly higher in the NFAI group.
Conclusion
There is increasing evidence that several cardiometabolic risk factors occur with higher prevalence in non-functioning adrenal incidentaloma patients compared to age-matched healthy subjects. In our study, hypertension prevalence and CIMT were higher in the NFAI group. Serum adipokine levels were similar for both groups.
Similar content being viewed by others
Abbreviations
- AI:
-
Adrenal incidentaloma
- CIMT:
-
Carotid intima media thickness
- CS:
-
Cushing’s syndrome
- DM:
-
Diabetes mellitus
- DST:
-
Dexamethasone suppression test
- FBG:
-
Fasting blood glucose
- HT:
-
Hypertension
- IR:
-
Insulin resistance
- MS:
-
Metabolic syndrome
- NFAI:
-
Non-functioning adrenal incidentaloma
- SCS:
-
Subclinical Cushing’s syndrome
References
Young WF Jr (2007) Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 356:601–610
Barzon L, Sonino N, Fallo F et al (2003) Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149:273–285
Mansmann G, Lau J, Balk E et al (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25:309–340
Mantero F, Arnaldi G (1999) Investigation protocol: adrenal enlargement. Clin Endocrinol (Oxf) 50:141–146
Morelli V et al (2014) Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. J Clin Endocrinol Metab 99:827–834
Reincke M, Fassnacht M, Vath S, Mora P, Allolio B (1996) Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocr Res 22:757–761
Chiodini I, Morelli V et al (2010) Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab 95(6):2736–2745
Yenigün M, Türker T, Ataoğlu HE et al (2005) From obesity to diabetes. Haseki Tıp Bülteni 43:1–12
Steppan CM, Lazar MA (2002) Rezistin and obesity-associated insulin resistance. Trends Endocrinol Metab 13:18–23
Mantero F, Terzolo M, Arnaldi G et al (2000) A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian society of endocrinology. J Clin Endocrinol Metab 85:637–644
Reincke M, Nieke J, Krestin GP et al (1992) Preclinical Cushing’s syndrome in adrenal incidentalomas: comparison with adrenal Cushing’s syndrome. J Clin Endocrinol Metab 75(3):826–832
Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
Beşir FH, Yazgan S, Celbek G, Aydın M et al (2012) Normal values correlates’ of carotid intima- media thickness and affecting parameters in healthy adults. Anadolu Kardiyol Derg 12(5):427–433
Zhang W, Tang ZY, Wang WQ et al (2006) Metabolic syndrome in patients with adrenocortical adenoma. Zhonghua Yi Xue Za Zhi 86:3397–3400
Wagnerova H, Dudasova D, Lazurova I (2009) Hormonal and metabolic evaluation of adrenal incidentalomas. Neoplasma 56:521–525
Comlekci A, Yener S, Ertilav S et al (2010) Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 37(1):40–46
Garrapa G, Paola P, Gıorgıo A et al (2001) Body composition in adrenal ıncidentaloma. J Clin Endocrinol Metab 86(11):5301–5306
Kastelein JJ, de Groot E (2008) Ultrasound imaging techniques for the evaluation of cardiovascular therapies. Eur Heart J 29:849–858
Yener S, Genc S, Akinci B et al (2009) Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma. Endocrine 35(3):365–370
Ermetici F, Malavazos AE, Corbetta S et al (2007) Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma. Metabolism 56(5):686–692
Terzolo M, Pia A, Alı A et al (2002) Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 87:998–1003
Harman E, Karadeniz M, Biray C et al (2009) The relation of adiponectin and tumor necrosis factor alpha levels between endothelial nitric oxide synthase, angiotensin-converting enzyme, transforming growth factor beta, and tumor necrosis factor alpha gene polymorphism in adrenal incidentalomas. J Endocrinol Invest 32(11):881–888
Lazúrová I, Spišáková D, Wagnerová H et al (2011) Clinically silent adrenal adenomas—their relation to the metabolic syndrome and to GNB3 C825T gene polymorphism. Wien Klin Wochenschr 123(19–20):618–622
Acknowledgments
This work was partially supported by Grants from Ankara Numune Training and Research Hospital.
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tuna, M.M., Imga, N.N., Doğan, B.A. et al. Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis. J Endocrinol Invest 37, 765–768 (2014). https://doi.org/10.1007/s40618-014-0106-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-014-0106-5